Angela Windt

Angela Windt has considerable work experience in regulatory affairs in the pharmaceutical industry. Angela is currently working at Bicara Therapeutics as the Vice President and Head of Regulatory Affairs. Prior to that, they worked at Novartis as the Global Program Regulatory Director for Oncology. Angela also held positions at Advyzom, where they served as Vice President of Regulatory Strategy from January 2019 to August 2021, and as Senior Director of Regulatory Strategy from July 2012 to August 2021. Before Advyzom, they worked at Roche in various regulatory roles, including Regulatory Program Director and Senior Program Manager. Angela's earlier experience includes working as a Per Diem Staff Pharmacist at Walgreens and as a Clinical Trials Intern at ImClone Systems, a subsidiary of Eli Lilly and Company.

Angela Windt's education history includes a Bachelor of Arts degree in Biology from Taylor University, which they obtained from 1995 to 1999. Later on, from 2001 to 2005, they attended Rutgers University, where they earned a Pharm.D. degree in Pharmacy.